A successful electroconvulsive treatment of neuroleptic malignant syndrome.
A case of neuroleptic malignant syndrome (NMS) treated successfully with electroconvulsive therapy (ETC) is described. Repeated exposures of the patients to succinylcholine during ECT did not cause malignant hyperthermia. The efficacy of ECT is probably related to its facilitatory effect upon dopamine (DA) activity in CNS.
D000328:Adult; D002746:Chlorpromazine / Q000009:adverse effects; D004565:Electroconvulsive Therapy; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000628:therapy*; D012559:Schizophrenia / Q000188:drug therapy; D013390:Succinylcholine / Q000627:therapeutic use
D013390:Succinylcholine; D002746:Chlorpromazine